Joshua Wilson, MD
Orthopaedic Surgery · Norman, OKNPI 1861848939
Payments from drug & device makers
What this record shows
The money is spread across several categories — grants (37.5%), education and food and beverage — rather than concentrated in one kind of arrangement. 14 manufacturers reported payments, led by Arthrex at 41.1% of the total. Reporting peaked in 2021 at $18,608 and has fallen 97.7% since, to $429 in 2025.
Across 142 payments — averaging $281.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$16K
- Pylant Medical$11K
- Smith+Nephew$6K
- Stryker$3K
- ALON Medical Technology$2K
- Johnson & Johnson$300
- plus $1K from 8 others
What the payments were for
- Grants$15,00037%
- Travel & lodging$3,85210%
- Food & beverage$6,69717%
- Education$14,47636%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 6 | $16,456 |
| Pylant Medical | 15 | $11,306 |
| Smith+Nephew | 66 | $5,654 |
| Stryker | 35 | $2,797 |
| ALON Medical Technology | 2 | $2,400 |
| Johnson & Johnson | 6 | $300 |
| Medical Device Business Services, Inc. | 2 | $285 |
| Zimmer Biomet | 3 | $265 |
| Tenex Health Inc. | 1 | $146 |
| Pacira Therapeutics, Inc. | 2 | $125 |
| Pacira Pharmaceuticals Incorporated | 1 | $125 |
| Vericel Corporation | 1 | $114 |
| Medacta USA, Inc. | 1 | $29 |
| Innovation Technologies Inc | 1 | $23 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FAST-FIX$2,013
- SPATIAL FRAME$1,354
- Q-FIX$1,226
- NA$922
- Bioinductive Implant with Arthroscopic Delivery System - Medium$904
- Healicoil$845
- MAKO$695
- Endobutton$644
- Mini-Open Latarjet$644
- TRIGEN InterTAN$248
- Zilretta$230
- TWINFIX$173
- GMRS$161
- EVOS$136
- Firstpass$132
- MICRORAPTOR$132
- LENS 4K$128
- ROSA-Knee$126
- Persona$125
- Iovera$125
How this compares
$40,025 in reported general payments places this provider in the 85th percentile of 263 orthopaedic surgery providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 94 | $869 |
| Ondansetron OdtOndansetron | 59 | $529 |
| Meloxicam | 15 | $94 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Norman
- Vytautas RingusNorman$272K
- Jeremiah MaupinNorman$20K
- James BondNorman$16K
- Yogesh MittalTulsa$6.6M
- Andrew ParkinsonOklahoma City$3.1M
- Bradley ReddickOklahoma City$573K
- Jason EmersonOklahoma City$189K
- Brian ChalkinTulsa$183K
- Ronald DumiganOklahoma City$169K
- Kasra AhmadiniaTulsa$138K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.